Related Experiment Videos
Defibrotide activity in experimental frostbite injury
I Ozyazgan1, M Tercan, M Bekerecioğlu
1Medical Faculty of Erciyes University, Kayseri, Turkey.
British Journal of Plastic Surgery
|December 16, 1998
Summary
Defibrotide treatment reduced inflammatory cells and increased prostaglandin I2 in rabbit frostbite injuries. This suggests Defibrotide may mitigate frostbite by targeting inflammatory processes.
Area of Science:
- Immunology
- Pharmacology
- Dermatology
Background:
- Frostbite pathogenesis is not fully understood, but evidence points to inflammation following reperfusion injury.
- Inflammatory mediators play a crucial role in the tissue damage observed in frostbite.
Purpose of the Study:
- To investigate the effect of Defibrotide on inflammatory markers in a rabbit model of frostbite.
- To explore Defibrotide's potential role in modulating the inflammatory response associated with frostbite injury.
Main Methods:
- Rabbits' ears were subjected to frostbite injury.
- Defibrotide was administered intraperitoneally (i.p.) at 40 mg/kg/day for three days.
- Inflammatory cell counts (mast cells, neutrophils) and prostaglandin I2 (PGI2) levels were measured in the affected skin.
Main Results:
- Defibrotide treatment significantly decreased mast cells (-76%) and neutrophils (-40.4%) in frostbite-injured rabbit ears.
- Prostaglandin I2 (PGI2) levels, measured as 6-Keto-PGF1 alpha, were increased following Defibrotide administration.
- Thromboxane A2 (TxA2) levels, measured as TxB2, remained unaffected by Defibrotide treatment.
Conclusions:
- The findings support the hypothesis that inflammation is a key component of frostbite injury pathogenesis.
- Defibrotide demonstrates efficacy in reducing inflammatory cell infiltration and modulating prostaglandin levels in frostbite.
- These results suggest Defibrotide may be a potential therapeutic agent for frostbite and other inflammatory conditions.